<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antiendothelial cell antibodies (AECA) have been detected in 20 out of 30 patients (67%) with <z:mp ids='MP_0005048'>thrombosis</z:mp> associated with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Seven patients had <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and 13 had the "primary" <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Seven patients had both IgG and IgM AECA, 9 had IgG AECA only, and 4 had only IgM AECA </plain></SENT>
<SENT sid="3" pm="."><plain>None of 30 control patients with thrombotic events not related to <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> had a positive titre of AECA (P less than 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>No correlation between AECA, <z:hpo ids='HP_0003493'>antinuclear antibodies</z:hpo>, anti-dsDNA antibodies, anti-neutrophil cytoplasm antibodies, precipitating antibodies to soluble nuclear and cytoplasmic antigens or complement components was found </plain></SENT>
<SENT sid="5" pm="."><plain>The possible role of these AECA in the pathogenesis of thrombotic events is discussed </plain></SENT>
</text></document>